Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles

By Heidari Majd Mostafa   Asgari Davoud   Barar Jaleh   Valizadeh Hadi   Kafil Vala   Coukos George   Omidi Yadollah  

Journal of Drug Targeting, Vol. 21, Iss. 4, 2013-05 ,pp. : 328-340

Informa Healthcare

Access to resources Recommend Favorite

Magnetic drug targeting in a rhabdomyosarcoma rat model using magnetite-dextran composite nanoparticle-bound mitoxantrone and 0.6 tesla extracorporeal magnets − sarcoma treatment in progress

By Krukemeyer Manfred Georg   Krenn Veit   Jakobs Martin   Wagner Wolfgang  

Journal of Drug Targeting, Vol. 20, Iss. 2, 2012-02 ,pp. : 185-193

Informa Healthcare

Access to resources Recommend Favorite

Genetic Polymorphisms of Drug-Metabolising Enzymes and Drug Transporters in the Chemotherapeutic Treatment of Cancer

By Bosch Tessa M.  

Clinical Pharmacokinetics, Vol. 45, Iss. 3, 2006-01 ,pp. : 253-285

Adis International

Access to resources Recommend Favorite

CD44-Targeting for Antitumor Drug Delivery: A New SN-38-Hyaluronan Bioconjugate for Locoregional Treatment of Peritoneal Carcinomatosis

By  

Current Cancer Drug Targets, Vol. 11, Iss. 5, 2011-06 ,pp. : 572-585

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Targeting Strategies in Cancer Treatment: An Overview

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 1, 2011-01 ,pp. : 1-17

Bentham Science Publishers

Access to resources Recommend Favorite